Stephens Consulting, LLC
- SEC CIK
- 0001961632
- Latest filing
- Jan 13, 2026
VRTX holding history
Vertex Pharmaceuticals Inc in every 13F filed by Stephens Consulting, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull Q4 2025 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −7−100.0% | Sold out | Holders |
| Q2 2025 | 7 | $3.12K | <0.1% | +7 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −55−100.0% | Sold out | Holders |
| Q4 2024 | 55 | $22.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 55 | $25.6K | <0.1% | −12−17.9% | Reduced | Holders |
| Q2 2024 | 67 | $31.4K | <0.1% | +67 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −132−100.0% | Sold out | Holders |
| Q3 2022 | 132 | $38.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 132 | $37.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 132 | $34.4K | <0.1% | −161−54.9% | Reduced | Holders |
| Q4 2021 | 293 | $64.3K | 0.1% | – | No prior filing | Holders |